Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000315066-18-001774
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-05 12:27:23
Reporting Period:
2018-04-03
Accepted Time:
2018-04-05 12:27:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1622229 Unum Therapeutics Inc. UMRX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
315066 Fmr Llc 245 Summer Street
Boston MA 02210
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-03 349,462 $0.00 349,462 No 4 C Indirect F-Prime Capital Partners Healthcare Fund IV LP
Common Stock Acquisiton 2018-04-03 8,601 $0.00 358,063 No 4 C Indirect F-Prime Capital Partners Healthcare Fund IV LP
Common Stock Acquisiton 2018-04-03 94,052 $12.00 452,115 No 4 P Indirect F-Prime Capital Partners Healthcare Fund IV LP
Common Stock Acquisiton 2018-04-03 1,890,701 $0.00 1,890,701 No 4 C Indirect Impresa Fund III Limited Partnership
Common Stock Acquisiton 2018-04-03 46,534 $0.00 1,937,235 No 4 C Indirect Impresa Fund III Limited Partnership
Common Stock Acquisiton 2018-04-03 22,682 $0.00 22,682 No 4 C Indirect F-Prime Capital Partners Healthcare Advisors Fund IV LP
Common Stock Acquisiton 2018-04-03 558 $0.00 23,240 No 4 C Indirect F-Prime Capital Partners Healthcare Advisors Fund IV LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect F-Prime Capital Partners Healthcare Fund IV LP
No 4 C Indirect F-Prime Capital Partners Healthcare Fund IV LP
No 4 P Indirect F-Prime Capital Partners Healthcare Fund IV LP
No 4 C Indirect Impresa Fund III Limited Partnership
No 4 C Indirect Impresa Fund III Limited Partnership
No 4 C Indirect F-Prime Capital Partners Healthcare Advisors Fund IV LP
No 4 C Indirect F-Prime Capital Partners Healthcare Advisors Fund IV LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2018-04-03 548,702 $0.00 349,462 $0.00
Common Stock Series A Preferred Stock Disposition 2018-04-03 2,968,650 $0.00 1,890,701 $0.00
Common Stock Series A Preferred Stock Disposition 2018-04-03 35,614 $0.00 22,682 $0.00
Common Stock Series B Preferred Stock Disposition 2018-04-03 13,505 $0.00 8,601 $0.00
Common Stock Series B Preferred Stock Disposition 2018-04-03 73,065 $0.00 46,534 $0.00
Common Stock Series B Preferred Stock Disposition 2018-04-03 877 $0.00 558 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. On April 3, 2018, in connection with the completion of the issuer's initial public offering, each 1.5701314513884 shares of Series A and Series B Preferred Stock converted into 1 share of Common Stock.